Updated May 7, 2025, 11:30 PM UTC
Income Statement - Metric | Q2 2021 | Q3 2021 | FY 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | FY 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | FY 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | FY 2024 | Q1 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (USD, thousands) | 100,545.00 | 403,094 | 114,103 | 103,676 | 156,815 | 117,550.00 | 492,144 | 133,452 | |||||||||||
Payment processing services costs (USD, thousands) | 36,780.00 | 147,339 | 41,650 | 39,899 | 54,557 | 41,384.00 | 177,490 | 50,563 | |||||||||||
Technology and development (USD, thousands) | 16,898.00 | 62,028 | 16,737 | 15,834 | 16,695 | 17,370.00 | 66,636 | 16,911 | |||||||||||
Selling and marketing (USD, thousands) | 28,830.00 | 107,621 | 30,083 | 31,771 | 34,228 | 33,353.00 | 129,435 | 36,569 | |||||||||||
General and administrative (USD, thousands) | 28,065.00 | 107,624 | 31,596 | 31,959 | 31,065 | 31,218.00 | 125,838 | 33,058 | |||||||||||
Restructuring (USD, thousands) | - | - | - | - | - | - | - | 7,339 | |||||||||||
Total costs and operating expenses (USD, thousands) | 110,573.00 | 424,612 | 120,066 | 119,463 | 136,545 | 123,325.00 | 499,399 | 144,440 | |||||||||||
Income (Loss) from operations (USD, thousands) | (10,028.00) | (21,518) | (5,963) | (15,787) | 20,270 | (5,775.00) | (7,255) | (10,988) | |||||||||||
Interest expense (USD, thousands) | (92.00) | (372) | (142) | (133) | (128) | (135.00) | (538) | (724) | |||||||||||
Interest income (USD, thousands) | 5,638.00 | 13,349 | 5,879 | 5,719 | 4,970 | 4,872.00 | 21,440 | 2,934 | |||||||||||
Gain (Loss) from remeasurement of foreign currency (USD, thousands) | 7,707.00 | 4,189 | (4,376) | 998 | 5,457 | (13,866.00) | (11,787) | 3,576 | |||||||||||
Total other income (expense), net (USD, thousands) | 13,253.00 | 17,166 | 1,361 | 6,584 | 10,299 | (9,129.00) | 9,115 | 5,944 | |||||||||||
Income (Loss) before (benefit from) provision for income taxes (USD, thousands) | 3,225.00 | (4,352) | (4,602) | (9,203) | 30,569 | (14,904.00) | 1,860 | (5,044) | |||||||||||
(Benefit from) Provision for income taxes (USD, thousands) | 1,938.00 | 4,214 | 1,615 | 4,677 | (8,327) | 995.00 | (1,040) | (884) | |||||||||||
Net income (Loss) (USD, thousands) | 1,287.00 | (8,566) | (6,217) | (13,880) | 38,896 | (15,899.00) | 2,900 | (4,160) | |||||||||||
Foreign currency translation adjustment (Other comprehensive income/Loss) (USD, thousands) | 3,731.00 | 3,232 | (1,361) | 193 | 4,904 | (7,330.00) | (3,594) | 2,677 | |||||||||||
Unrealized gains (losses) on available-for-sale debt securities, net of taxes (Other comprehensive income/Loss) (USD, thousands) | - | - | - | (53) | 702 | - | 208 | (129) | |||||||||||
Total other comprehensive income (Loss) (USD, thousands) | 3,731.00 | 3,232 | (1,361) | 140 | 5,606 | (7,771.00) | (3,386) | 2,548 | |||||||||||
Comprehensive income (Loss) (USD, thousands) | 5,018.00 | (5,334) | (7,578) | (13,740) | 44,502 | (23,670.00) | (486) | (1,612) | |||||||||||
Net income (Loss) attributable to common stockholders - basic and diluted (USD, thousands) | 1,287.00 | (8,566) | (6,217) | (13,880) | 38,896 | (15,899.00) | 2,900 | (4,160) | |||||||||||
Net income (Loss) per share attributable to common stockholders - basic (USD) | 0.02 | (0.07) | (0.05) | (0.11) | 0.31 | (0.13) | 0.02 | (0.03) | |||||||||||
Net income (Loss) per share attributable to common stockholders - diluted (USD) | 0.03 | (0.07) | (0.05) | (0.11) | 0.30 | (0.12) | 0.02 | (0.03) | |||||||||||
Weighted average common shares outstanding - basic (Shares) | (222,584,446.00) | 114,828,494 | 123,143,343 | 124,562,015 | 124,887,591 | (248,323,129.00) | 124,269,820 | 123,235,263 | |||||||||||
Weighted average common shares outstanding - diluted (Shares) | (231,572,648.00) | 114,828,494 | 123,143,343 | 124,562,015 | 129,155,010 | (247,520,906.00) | 129,339,462 | 123,235,263 | |||||||||||
Balance Sheet - Metric | Q2 2021 | Q3 2021 | FY 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | FY 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | FY 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | FY 2024 | Q1 2025 |
Cash and cash equivalents (USD, thousands) | - | - | - | 539,300 | 565,035 | 495,242 | 495,242 | 190,507 | |||||||||||
Accounts receivable, net of allowance (USD, thousands) | - | - | - | 20,275 | 27,510 | 23,703 | 23,703 | 33,585 | |||||||||||
Unbilled receivables, net of allowance (USD, thousands) | - | - | - | 13,052 | 11,659 | 15,453 | 15,453 | 11,431 | |||||||||||
Funds receivable from payment partners (USD, thousands) | - | - | - | 84,974 | 130,391 | 90,110 | 90,110 | 64,237 | |||||||||||
Prepaid expenses and other current assets (USD, thousands) | - | - | - | 21,633 | 24,847 | 22,528 | 22,528 | 31,947 | |||||||||||
Total current assets (USD, thousands) | - | - | - | 710,928 | 875,533 | 762,884 | 762,884 | 396,530 | |||||||||||
Property and equipment, net (USD, thousands) | - | - | - | 17,074 | 17,684 | 17,160 | 17,160 | 17,391 | |||||||||||
Intangible assets, net (USD, thousands) | - | - | - | 101,303 | 126,966 | 118,684 | 118,684 | 202,014 | |||||||||||
Goodwill (USD, thousands) | - | - | - | 120,657 | 156,292 | 149,558 | 149,558 | 402,715 | |||||||||||
Other assets (USD, thousands) | - | - | - | 22,029 | 23,200 | 24,035 | 24,035 | 23,629 | |||||||||||
Total assets (USD, thousands) | - | - | - | 998,712 | 1,240,032 | 1,122,446 | 1,122,446 | 1,060,348 | |||||||||||
Accounts payable (USD, thousands) | - | - | - | 13,509 | 23,182 | 15,353 | 15,353 | 15,069 | |||||||||||
Funds payable to clients (USD, thousands) | - | - | - | 116,191 | 298,239 | 217,788 | 217,788 | 106,613 | |||||||||||
Accrued expenses and other current liabilities (USD, thousands) | - | - | - | 43,536 | 46,227 | 49,297 | 49,297 | 53,022 | |||||||||||
Deferred revenue (USD, thousands) | - | - | - | 4,183 | 7,692 | 7,337 | 7,337 | 21,228 | |||||||||||
Total current liabilities (USD, thousands) | - | - | - | 177,419 | 375,340 | 289,775 | 289,775 | 195,932 | |||||||||||
Deferred tax liabilities (USD, thousands) | - | - | - | 14,744 | 15,573 | 12,643 | 12,643 | 13,216 | |||||||||||
Long-term debt (USD, thousands) | - | - | - | - | - | - | - | 60,000 | |||||||||||
Other liabilities (USD, thousands) | - | - | - | 3,989 | 5,874 | 5,261 | 5,261 | 6,935 | |||||||||||
Total liabilities (USD, thousands) | - | - | - | 196,152 | 396,787 | 307,679 | 307,679 | 276,083 | |||||||||||
Preferred stock, $ 0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Voting common stock, $ 0.0001 par value; 2,000,000,000 shares authorized; shares issued and outstanding (USD, thousands) | - | - | - | 11 | 13 | 13 | 13 | 13 | |||||||||||
Non-voting common stock, $ 0.0001 par value; 10,000,000 shares authorized; shares issued and outstanding (USD, thousands) | - | - | - | 1 | - | - | - | - | |||||||||||
Treasury voting common stock, shares held at cost (USD, thousands) | - | - | - | (741) | (23,851) | (46,268) | (46,268) | (94,489) | |||||||||||
Additional paid-in capital (USD, thousands) | - | - | - | 997,057 | 1,016,349 | 1,033,958 | 1,033,958 | 1,053,289 | |||||||||||
Accumulated other comprehensive income (loss) (USD, thousands) | - | - | - | 99 | 5,705 | (2,066) | (2,066) | 482 | |||||||||||
Accumulated deficit (USD, thousands) | - | - | - | (193,867) | (154,971) | (170,870) | (170,870) | (175,030) | |||||||||||
Total stockholders’ equity (USD, thousands) | - | - | - | 802,560 | 843,245 | 814,767 | 814,767 | 784,265 | |||||||||||
Total liabilities and stockholders’ equity (USD, thousands) | - | - | - | 998,712 | 1,240,032 | 1,122,446 | 1,122,446 | 1,060,348 | |||||||||||
Cash Flow - Metric | Q2 2021 | Q3 2021 | FY 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | FY 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | FY 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | FY 2024 | Q1 2025 |
Net loss (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Depreciation and amortization (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Stock-based compensation expense (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Amortization of deferred contract costs (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Change in fair value of contingent consideration (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Deferred tax provision (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Bad debt expense (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Non-cash interest expense (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Changes in operating assets and liabilities: Accounts receivable (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Changes in operating assets and liabilities: Unbilled receivables (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Changes in operating assets and liabilities: Funds receivable from payment partners (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Changes in operating assets and liabilities: Prepaid expenses and other current assets (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Changes in operating assets and liabilities: Funds payable to clients (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Changes in operating assets and liabilities: Accounts payable, accrued expenses and other current liabilities (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Changes in operating assets and liabilities: Contingent consideration (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Changes in operating assets and liabilities: Other liabilities (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Changes in operating assets and liabilities: Deferred revenue (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Net cash used in operating activities (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Cash flows from investing activities: Purchases of property and equipment (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Net cash used in investing activities (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Cash flows from financing activities: Contingent consideration paid for acquisitions (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Cash flows from financing activities: Payments of tax withholdings for net settled option exercises (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Cash flows from financing activities: Proceeds from exercise of stock options (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Net cash (used in) provided by financing activities (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Effect of exchange rates changes on cash and cash equivalents (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Net (decrease) increase in cash, cash equivalents and restricted cash (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Supplemental disclosures of cash flow and noncash information: Cash paid during the period for interest (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Supplemental disclosures of cash flow and noncash information: Purchase of property and equipment in accounts payable (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Cash, cash equivalents and restricted cash, beginning of period (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Cash, cash equivalents and restricted cash, end of period (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Reconciliation of cash, cash equivalents and restricted cash: Cash and cash equivalents (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Reconciliation of cash, cash equivalents and restricted cash: Restricted cash (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Reconciliation of cash, cash equivalents and restricted cash: Cash, cash equivalents and restricted cash (USD, thousands) | - | - | - | - | - | - | - | - | |||||||||||
Revenue by Segment - in Millions of USD | Q2 2021 | Q3 2021 | FY 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | FY 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | FY 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | FY 2024 | Q1 2025 |
Transaction Revenue | 82 | 329.7 | 95.2 | 85.3 | 134.4 | 95.3 | 410.2 | 108.5 | |||||||||||
- Less Ancillary Services | 14.6 | 54.0 | 15.3 | 14.8 | - | - | - | 20.6 | |||||||||||
Platform and Other Revenues | 18.6 | 73.4 | 18.9 | 18.4 | 22.4 | 22.2 | 81.9 | 25.0 | |||||||||||
Sertifi Revenue Contribution | - | - | - | - | - | - | - | - | |||||||||||
FX Neutral Revenue Less Ancillary Services | - | - | - | - | - | - | - | 130.7 | |||||||||||
Total Revenue | 100.5 | 403.1 | 114.1 | 103.7 | 156.8 | 117.5 | 492.1 | 133.5 | |||||||||||
Revenue by Geography - in Millions of USD | Q2 2021 | Q3 2021 | FY 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | FY 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | FY 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | FY 2024 | Q1 2025 |
Americas | 50.72 | 222.58 | 57.9 | 41.96 | 71.56 | 50.18 | 221.6 | 63.4 | |||||||||||
- United States | - | - | - | - | - | - | - | - | |||||||||||
- Canada | - | - | - | - | - | - | - | - | |||||||||||
EMEA | 30.18 | 120.84 | 36.2 | 42.87 | 63.8 | 46.03 | 188.9 | 47.4 | |||||||||||
- United Kingdom | - | - | - | - | - | - | - | - | |||||||||||
APAC | 19.74 | 59.67 | 20.1 | 18.84 | 21.46 | 21.3 | 81.7 | 22.6 | |||||||||||
Other | - | - | - | - | - | - | - | - | |||||||||||
Total Revenue | 100.53 | 403.09 | 114.1 | 103.68 | 156.82 | 117.5 | 492.1 | 133.5 | |||||||||||
KPIs - Metric (Unit, Scale) | Q2 2021 | Q3 2021 | FY 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | FY 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | FY 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | FY 2024 | Q1 2025 |
Transaction payment volume (USD millions) | - | 17,670.3 | 7,000.0 | 11,800.0 | 8,776.1 | - | 23,207.6 | - | |||||||||||
Platform and other revenues payment volume (USD millions) | - | 6362.5 | 2000 | - | 2234.7 | - | 6507.7 | - | |||||||||||
Total payment volume (USD millions) | - | 24,032.8 | 7,000 | 11,800 | 11,010.8 | - | 29,715.3 | - | |||||||||||
Annual net dollar-based retention rate (percentage) | - | 125 | - | - | - | - | 114 | - | |||||||||||
Number of total clients around the world (count) | - | 3800 | 4000 | 4000 | 4000 | - | 4500 | - | |||||||||||
Number of education institutions (count) | - | 2,800 | 2,850 | 2,950 | 2,960 | - | 3,100 | - | |||||||||||
Number of healthcare systems (count) | - | 90 | 90 | 90 | 100 | - | 100 | - | |||||||||||
Number of travel and B2B clients (count) | - | 900 | 1000 | 1100 | 1200 | - | 1300 | - |